
Global Aortic Stent Graft Market Report and Forecast 2024-2032
Description
Global Aortic Stent Graft Market Report and Forecast 2024-2032
Global Aortic Stent Graft Market Report and Forecast 2024-2032
The global aortic stent graft market size was valued at USD 3.1 billion in 2023. It is expected to grow at a CAGR of 5.80% during the forecast period of 2024-2032, driven by increasing preference for minimally invasive procedures across the globe. The market is experiencing robust growth and is expected to reach USD 5.2 billion by 2032.
Global Aortic Stent Graft Market Analysis
Aortic stent grafts are medical devices used to reinforce and support weakened sections of the aorta, such as in the case of an abdominal aortic aneurysm (AAA) or thoracic aortic aneurysm (TAA). The market for these devices is expanding due to the growing incidence of aortic aneurysms and the need for effective treatment options.
Market Drivers
- Increasing Prevalence of Aortic Aneurysms: The rising incidence of AAA and TAA is a primary driver for the demand for aortic stent grafts.
- Technological Advancements: Innovations in stent graft design and materials are enhancing their effectiveness and durability.
- Rising Demand for Minimally Invasive Procedures: The preference for less invasive endovascular procedures over traditional open surgeries is fueling market growth.
- Aging Population: The growing elderly population, which is more susceptible to aortic aneurysms, is further driving the demand for stent grafts.
- High Cost of Devices and Procedures: The elevated price of aortic stent grafts and associated procedures can limit their accessibility, particularly in low- and middle-income countries.
- Risk of Complications: The potential risks and complications associated with stent graft placement, such as endoleaks and migration, can impact market growth.
- Emerging Markets: Expanding healthcare infrastructure and increasing awareness in emerging economies present significant growth opportunities.
- Advancements in Imaging Technologies: Improvements in imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI), are enhancing the precision of stent graft placement.
- Regulatory Hurdles: Stringent regulatory requirements for the approval of medical devices can delay the introduction of new stent grafts to the market.
- Reimbursement Issues: Variability in reimbursement policies across different regions can impact the adoption of aortic stent grafts.
The global aortic stent graft market is expected to grow at a significant CAGR during the forecast period. The market's growth prospects are promising due to the ongoing advancements in stent graft technologies and the increasing preference for minimally invasive treatments.
The global aortic stent graft market is poised for significant growth, driven by the rising burden of aortic aneurysms and technological innovations in stent graft design. The market presents opportunities for companies to innovate and expand their product offerings to meet the evolving needs of patients and healthcare providers.
Global Aortic Stent Graft Market Trends
The global aortic stent graft market is witnessing significant growth, driven by advancements in medical technology, an aging population, and an increasing prevalence of aortic aneurysms. This market is characterized by several key trends that are shaping its current landscape and future outlook.
- Technological Advancements
- Minimally Invasive Procedures
- Rising Incidence of Aortic Aneurysms
- Regulatory and Reimbursement Challenges
- Market Expansion in Emerging Economies
In conclusion, the global aortic stent graft market is poised for continued growth, driven by technological innovations, the preference for minimally invasive procedures, and the increasing prevalence of aortic aneurysms. However, market players must navigate the challenges of regulatory approvals and develop strategies to tap into the potential of emerging markets to maintain and enhance their market positions.
Global Aortic Stent Graft Market Segmentation
Market Breakup by Product
- Abdominal Aortic Stent Graft
- Thoracic Aortic Stent Graft
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Aortic Stent Graft Market Competitive Landscape
The competitive landscape of the global aortic stent graft market is marked by the presence of established players and emerging enterprises, contributing to a dynamic and innovative market environment. Leading companies include Cook Group Incorporated, W. L. Gore & Associates, Inc., Medtronic, Terumo Corporation, Cordis, Artivion, Inc., Endologix LLC, Lombard Medical, SB-KAWASUMI LABORATORIES, INC., Endospan, LifeTech Scientific Corporation, Shanghai MicroPort Medical (Group) Co. Ltd., Cardinal Health, and Becton, Dickinson and Company.
Key Questions Answered in the Report
- What is the current and future performance of the global aortic stent graft market?
- What are the key drivers and challenges in the aortic stent graft market?
- What are the significant trends and challenges shaping the global aortic stent graft market?
- How is the global aortic stent graft market segmented on the basis of products, and what drives the growth of these segments?
- What is the market breakup based on end users?
- How do regional dynamics affect the global aortic stent graft market?
- What factors contribute to North America leading the global aortic stent graft market?
- What are the main players/companies in the market?
- The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global aortic stent graft market from 2017-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the global aortic stent graft market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global aortic stent graft industry and its attractiveness.
- The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Aortic Stent Graft Market Overview
- 3.1 Global Aortic Stent Graft Market Historical Value (2017-2023)
- 3.2 Global Aortic Stent Graft Market Forecast Value (2024-2032)
- 4 Global Aortic Stent Graft Market Landscape*
- 4.1 Global Aortic Stent Graft Market: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Aortic Stent Graft Market: Product Landscape
- 4.2.1 Analysis by Product
- 5 Global Aortic Stent Graft Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Aortic Stent Graft Market Segmentation (2017-2032)
- 6.1 Global Aortic Stent Graft Market (2017-2032) by Product
- 6.1.1 Market Overview
- 6.1.2 Abdominal Aortic Stent Graft
- 6.1.3 Thoracic Aortic Stent Graft
- 6.2 Global Aortic Stent Graft Market (2017-2032) by End User
- 6.2.1 Market Overview
- 6.2.2 Hospitals
- 6.2.3 Ambulatory Surgical Centers
- 6.2.4 Others
- 6.3 Global Aortic Stent Graft Market (2017-2032) by Region
- 6.3.1 Market Overview
- 6.3.2 North America
- 6.3.3 Europe
- 6.3.4 Asia Pacific
- 6.3.5 Latin America
- 6.3.6 Middle East and Africa
- 7 North America Aortic Stent Graft Market (2017-2032)
- 7.1 North America Aortic Stent Graft Market (2017-2032) by Product
- 7.1.1 Market Overview
- 7.1.2 Abdominal Aortic Stent Graft
- 7.1.3 Thoracic Aortic Stent Graft
- 7.2 North America Aortic Stent Graft Market (2017-2032) by Country
- 7.2.1 United States of America
- 7.2.2 Canada
- 8 Europe Aortic Stent Graft Market (2017-2032)
- 8.1 Europe Aortic Stent Graft Market (2017-2032) by Product
- 8.1.1 Market Overview
- 8.1.2 Abdominal Aortic Stent Graft
- 8.1.3 Thoracic Aortic Stent Graft
- 8.2 Europe Aortic Stent Graft Market (2017-2032) by Country
- 8.2.1 United Kingdom
- 8.2.2 Germany
- 8.2.3 France
- 8.2.4 Italy
- 8.2.5 Others
- 9 Asia Pacific Aortic Stent Graft Market (2017-2032)
- 9.1 Asia Pacific Aortic Stent Graft Market (2017-2032) by Product
- 9.1.1 Market Overview
- 9.1.2 Abdominal Aortic Stent Graft
- 9.1.3 Thoracic Aortic Stent Graft
- 9.2 Asia Pacific Aortic Stent Graft Market (2017-2032) by Country
- 9.2.1 China
- 9.2.2 Japan
- 9.2.3 India
- 9.2.4 ASEAN
- 9.2.5 Australia
- 9.2.6 Others
- 10 Latin America Aortic Stent Graft Market (2017-2032)
- 10.1 Latin America Aortic Stent Graft Market (2017-2032) by Product
- 10.1.1 Market Overview
- 10.1.2 Abdominal Aortic Stent Graft
- 10.1.3 Thoracic Aortic Stent Graft
- 10.2 Latin America Aortic Stent Graft Market (2017-2032) by Country
- 10.2.1 Brazil
- 10.2.2 Argentina
- 10.2.3 Mexico
- 10.2.4 Others
- 11 Middle East and Africa Aortic Stent Graft Market (2017-2032)
- 11.1 Middle East and Africa Aortic Stent Graft Market (2017-2032) by Product
- 11.1.1 Market Overview
- 11.1.2 Abdominal Aortic Stent Graft
- 11.1.3 Thoracic Aortic Stent Graft
- 11.2 Middle East and Africa Aortic Stent Graft Market (2017-2032) by Country
- 11.2.1 Saudi Arabia
- 11.2.2 United Arab Emirates
- 11.2.3 Nigeria
- 11.2.4 South Africa
- 11.2.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Cook Group Incorporated
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 W. L. Gore & Associates, Inc.
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Medtronic
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Terumo Corporation
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Cordis
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Artivion, Inc
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Endologix LLC
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Lombard Medical
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 SB-KAWASUMI LABORATORIES, INC.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Endospan
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 LifeTech Scientific Corporation
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Shanghai MicroPort Medical (Group) Co. Ltd.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Cardinal Health
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Becton, Dickinson and Company
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 18 Global Aortic Stent Graft Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.